FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

GLOBAL HEALTH Previous Volume 351:738-742 August 19, 2004 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Steinbrook, R. PubMed Citation

The progress that has been made in the global response to AIDS is real — but inadequate. An estimated 1 million people throughout the world are now using antiretroviral medications for human immunodeficiency virus (HIV) infection — double the number who were receiving such treatment two years ago. As of June 2004, 440,000 people from low- and middle-income countries were being treated.¹ About 125,000 were from sub-Saharan Africa, where the burden is the greatest, an increase of 100,000 in two years. Spending on AIDS in low- and middle-income countries has increased from $1.0 billion in 2000 to $3.9 billion in . . . [Full Text of this Article]

This article has been cited by other articles:

• Tantivess, S., Walt, G. (2008). The role of state and non-state actors in the policy process: the contribution of policy networks to the scale-up of antiretroviral therapy in Thailand. Health Policy Plan 23: 328-338 [Abstract] [Full Text]  
• Rosen, M. J. (2006). Cough in the Immunocompromised Host: ACCP Evidence-Based Clinical Practice Guidelines. Chest 129: 204S-205S [Abstract] [Full Text]